How much funding has Prenuvo raised?

Prenuvo has raised $190.0M in total funding, most recently a Series B round.

Who are Prenuvo's investors?

Prenuvo's investors include Left Lane Capital, Forerunner Ventures, Felicis Ventures, Tony Fadell.

Where is Prenuvo headquartered?

Prenuvo is headquartered in Redwood City, California, United States.

What industry is Prenuvo in?

Prenuvo operates in Healthcare.

Prenuvo

The world's most advanced whole-body proactive health scan.

Redwood City, United States · Founded 2018 · $190.0M raised

Healthcare

Headquarters: Redwood City, California
Employees: 51–200
Founded: 2018
Business Model: B2C

Website: prenuvo.com
Total Funding: $190.0M
Last Round: $120.0M Series BJan 2024
Rounds: 2

About

Prenuvo is a preventive health company pioneering whole-body MRI scanning for early disease detection. Founded in 2018 in Vancouver, Canada, by CEO Andrew Lacy and radiologist Dr. Raj Attariwala, Prenuvo offers comprehensive, radiation-free MRI scans that screen for hundreds of conditions — including cancers, aneurysms, and organ diseases — often before symptoms appear. The company combines advanced MRI technology with AI-powered analysis and expert radiologists to deliver actionable health insights. Prenuvo has expanded from its Canadian roots to operate scanning clinics across the United States and has attracted investment from notable figures including 23andMe co-founder Anne Wojcicki. As of 2024, Prenuvo has completed over 100,000 scans and raised more than $120M in Series B funding.

Summary

Prenuvo is a Healthcare company based in Redwood City, United States, founded in 2018. It has raised $190.0M in total across 2 rounds, most recently a $120.0M Series B round in Jan 2024. Investors include Left Lane Capital, Forerunner Ventures and Felicis Ventures.

LinkedIn X (Twitter)